Cyclodextrin complexation
PREPARATION AND EVALUATION OF CYCLODEXTRIN COMPLEXATION OF ETORICOXIB
7
INFLUENCE OF β-CYCLODEXTRIN COMPLEXATION ON KETOPROFEN RELEASE FROM MATRIX FORMULATION
8
“FORMULATION AND EVALUATION OF NORFLOXACIN SUSPENSION WITH β-CYCLODEXTRIN COMPLEXATION” by Madhulita Panda*, Ganesh Patro, Amol Malpani, M. E. Bhanoji Rao, India.
5
RECENT RESEARCH ON CYCLODEXTRIN COMPLEXATION IN FORMULATION DEVELOPMENT- A REVIEW
8
Effect of β Cyclodextrin complexation on the solubility and dissolution rate of carbamazepine from tablets
7
The hydroxypropyl–β-cyclodextrin complexation of toltrazuril for enhancing bioavailability
7
COMPARATIVE EVALUATION OF CYCLODEXTRIN COMPLEXATION IN IMPROVING DISSOLUTION OF RITONAVIR
18
Effect of Cyclodextrin Complexation on the Aqueous Solubility of Diazepam and Nitrazepam: Phase Solubility Analysis, Thermodynamic Properties
9
Development of prednisolone-containing eye drop formulations by cyclodextrin complexation and antimicrobial, mucoadhesive biopolymer
9
RELEASE ENHANCEMENT OF MELOXICAM FROM TRANSDERMAL GEL THROUGH CYCLODEXTRIN COMPLEXATION
9
STUDIES ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF RITONAVIR EMPLOYING ? CYCLODEXTRIN, SOLUPLUS AND PVPK30
11
RECENT RESEARCH ON SOLID DISPERSIONS - A REVIEW
12
Enhanced Solubility of Modafinil via Solubilization Techniques
6
ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF TELMISARTAN EMPLOYING β-CYCLODEXTRIN AND SOLUPLUS – A FACTORIAL STUDYN.Tirumalesh and K. P. R. Chowdary* DOWNLOAD/VIEW
5
FORMULATION OF NICERDIPINE HYDROCHLORIDE INCLUSION COMPLEX FOR DISSOLUTION ENHANCEMENT
6
Enhanced dissolution and solubility of Epalrestat with β-Cyclodextrin ternary complex using Arginine
6
ENHANCEMENT OF SOLUBILITY BY COMPLEXATION WITH CYCLODEXTRIN AND NANOCRYSTALLISATION
6
Cyclodextrin Ternary Inclusion Complexation: A Strategy to Improve Solubility of Poorly Soluble Drugs
10
INCLUSION COMPLEXATION BY CYCLODEXTRIN : A NOVEL APPROACH TO IMPROVE SOLUBILITY AND BIOAVAILABILITY OF POORLY WATER SOLUBLE DRUG
14
CYCLODEXTRIN BASED NANOSPONGES: OPTIMIZATION OF REACTION CONDITIONS AND COMPLEXATION WITH HYDROPHILIC AND LIPOPHILIC DRUGS
22